(For Research Use Only — Not for Human Consumption)

Step into the cutting-edge of alkaloid science with MGM-15, a synthetic derivative crafted for laboratory exploration. Each tablet contains 5 mg of MGM-15, for your experimental protocols. This is not a wellness supplement — it is a research reagent, meant solely for in vitro or preclinical investigation.

We envision the mad scientist’s lab meeting the frontier of chemical discovery. MGM-15 takes the indole scaffold of kratom’s mitragynine lineage and transforms it into a new, powerful derivative — a compound designed for potency, selectivity, and investigative insight.

⚗️ Key Features & Use Notes

5 mg per tablet
Designed for research only: Not intended for ingestion by humans.
Synthetic semi-derivative: Engineered from the 7-hydroxymitragynine (7OH) backbone, incorporating structural modifications for altered receptor binding.
Stability & handling: Store in a cool, dry environment, sealed from light and moisture. Use proper lab-standard protective protocols when handling.

Scientific & Mechanistic Context

MGM-15 is one of several semi-synthetic analogues derived from 7-hydroxymitragynine (7OH).
In prior research, MGM-15 was synthesized via reduction modifications of 7OH to generate novel analogues with altered pharmacology.
Early comparative studies suggest that while MGM-16 (a related analogue) demonstrates enhanced potency over 7OH, MGM-15 remains a valuable intermediary with distinct receptor behavior.
Because MGM-15 alters the indole/indolenine core and associated substituents, its binding affinity, efficacy, and receptor selectivity may differ substantially from natural 7OH.

Due to the novelty and limited published data on MGM-15, buyers of this compound are strongly encouraged to review peer literature and design controls accordingly.

Disclaimer (Again): This product is strictly for laboratory and research use. It is not for human or animal consumption. By handling MGM-15, you accept full responsibility for its use, storage, safety protocols, and any outcomes in your work.